Injectable Drug Delivery Devices Market Competitive Landscape 2024-2033 – Major Players and Strategies

Overview and Scope
Injectable drug delivery devices are used for various routes of drug administration, such as intravenous, subcutaneous, intradermal, intra-peritoneal, and intra-muscular.

Sizing and Forecast
The injectable drug delivery devices market size has grown strongly in recent years. It will grow from $43.54 billion in 2023 to $47.46 billion in 2024 at a compound annual growth rate (CAGR) of 9.0%.  The  growth in the historic period can be attributed to rapid growth in the elderly population, growth in the number of healthcare facilities, increased healthcare expenditure, growth in the biologics, and increasing awareness of self-administration.

The injectable drug delivery devices market size is expected to see strong growth in the next few years. It will grow to $61.78 billion in 2028 at a compound annual growth rate (CAGR) of 6.8%.  The growth in the forecast period can be attributed to increasing prevalence of chronic diseases, increasing demand for injectable drugs, sudden emergence of severe infections and large numbers of drugs and vaccines in several clinical trial stages. Major trends in the forecast period include focus on developing microneedle-based drug delivery systems, invest in the research and development of self-injectable devices, focus on manufacturing wearable devices, focus on the manufacturing of needle-free injection system, expanding its product line to prefilled syringes, consider improving the digital technology of their devices, focus on manufacturing innovative devices and focus on manufacturing innovative auto-injectors. .

Order your report now for swift delivery, visit the link:
https://www.thebusinessresearchcompany.com/report/injectable-drug-delivery-devices-global-market-report

Segmentation & Regional Insights
The injectable drug delivery devices market covered in this report is segmented –
1) By Type: Syringes, Injectors And Pump
2) By Application: Autoimmune Diseases, Hormonal Disorders, Oncology, Orphan Diseases, Pain Management, Respiratory Therapy, Other Applications
3) By End-user: Hospitals And Clinics, Home Healthcare Settings, Pharmaceutical And Biotechnological Companies, Research Laboratories, Other End Users

Sub segments: Conventional Injectable Devices, Pre-Filled Syringes, Auto-Injectors, Pen-Injectors, Insulin Pumps, Ambulatory Infusion Devices

North America was the largest region in the injectable drug delivery devices market in 2023. Western Europe was the second-largest region in the global injectable drug delivery devices market. The regions covered in the injectable drug delivery devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Intrigued to explore the contents? Secure your hands-on a free sample copy of the report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=2835&type=smp

Major Driver Impacting Market Growth
The increasing preference for self-injection devices is driving the injectable drug delivery devices market. Self-injection devices are medical devices that can be used by the patient in a home setting for self-administration of the medication. Self-injection devices include needle-free, auto, pen, and wearable injectors. These self-injectables were developed to provide the most adaptable device that has  high precision of drug delivery and is easy to use. In addition, with the innovations in self-injectable devices, the acceptance of these products has increased over the past few years. BD Physioject is a disposable auto-injector, manufactured by Becton, Dickinson, and Company, that is clinically proven, reliable, and cost-effective and specifically designed for self-injection of drugs by patients suffering from chronic diseases, including rheumatoid arthritis, multiple sclerosis, asthma, and osteoporosis. The other companies currently involved in the self-injections market include Abbvie, Inc., 3M, Baxter, Gerresheimer AG, Pfizer Inc., and more. The advantages of self-injectable injections and increasing awareness of self-administration have increased the demand for self-injectable devices and will drive the injectable drug delivery devices market during the forecast period.

Key Industry Players
Major companies operating in the injectable drug delivery devices market report are Becton, Dickinson and Company, Baxter International, Gerresheimer AG, B. Braun Melsungen AG, Catalent, Inc., SkyePharma PLC, Antares Pharma, Pfizer Inc, GE Healthcare, Owen Mumford, Catalent Pharma Solutions, Philips, West Pharmaceutical Services, Inc., Alkermes, Schott AG, UCB, AstraZeneca, Johnson & Johnson, NEARMEDIC PLUS LLC, Pendant Biosciences, Siemens, H&T Presspart, B Braun, Copernicus, Ypsomed AG, 3M Company, Aptar, Congenica Ltd., Julphar, Nemera, Stryker, Roche, Nektar Therapeutics, Eli Lilly, Merck & Co. Inc., Sandoz, Sorrel Medical, Teleflex Medical, Gilero, Teva Pharmaceutical Industries Ltd., GlaxoSmithKline, MediPrint Ophthalmics, Medtronic, Novartis, Pharmasyntez, Bayer, Mylan N.V, Aptalis Pharma, Inc., Sanofi, Novo Nordisk, Bilim Pharmaceuticals, Battelle Medical Devices, Caplin Steriles Limited, Abbot, Allergan, Boehringer Ingelheim, Hovione Technology, Jiangsu Delfu Medical Device Co, Ltd., Syqe Medical, Terumo Corporation, Kedalion Therapeutics, Amgen Inc.

The injectable drug delivery devices market report table of contents includes:
1. Executive Summary
2. Injectable Drug Delivery Devices Market Characteristics
3. Injectable Drug Delivery Devices Market Trends And Strategies
4. Injectable Drug Delivery Devices Market - Macro Economic Scenario
5. Global Injectable Drug Delivery Devices Market Size and Growth
…………….
32. Global Injectable Drug Delivery Devices Market Competitive Benchmarking
33. Global Injectable Drug Delivery Devices Market Competitive Dashboard
34. Key Mergers And Acquisitions In The Injectable Drug Delivery Devices Market
35. Injectable Drug Delivery Devices Market Future Outlook and Potential Analysis
36. Appendix